Aurobindo uses patent pool for generic AIDS drugs

LONDON Tue Oct 11, 2011 4:38pm IST

Students hold oil lamps beside a symbol of AIDS to mark the World AIDS Day in Chennai December 1, 2009. REUTERS/Babu/fILES

Students hold oil lamps beside a symbol of AIDS to mark the World AIDS Day in Chennai December 1, 2009.

Credit: Reuters/Babu/fILES

Related Topics

LONDON (Reuters) - Aurobindo Pharma has become the first major generic drugmaker to join a patent pool designed to make HIV/AIDS treatments more widely available to the poor, paving the way for it to sell cheap medicines in many countries.

The Medicines Patent Pool said on Tuesday the agreement would allow Aurobindo to make a range of AIDS drugs licensed to the pool by Gilead Sciences, the leading maker of HIV drugs, in July.

Aurobindo has also elected to take advantage of a key provision in the pool's licences in order to sell one drug, tenofovir, to a wide range of countries without paying royalties. These could include several middle-income countries such as Argentina, Brazil, Chile, Colombia, Malaysia, the Philippines, Ukraine and Uruguay.

Around 33 million people worldwide have the human immunodeficiency virus (HIV) that causes AIDS. Most live in Africa and Asia, where medicines have to be very cheap to allow those who need them to be able to afford them.

The Medicines Patent Pool, launched by the UNITAID health financing system that is funded by a tax on airline tickets, aims to address the problem by creating a system for patent holders to license technology to makers of cheap generics.

(Reporting by Ben Hirschler; Editing by David Holmes)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

ENVIRONMENT

Reuters Showcase

Ganga Clean-up

Ganga Clean-up

Give the public a role in Clean Ganga project, says Rajendra Pachauri.  Full Article 

Kashmir Floods

Kashmir Floods

Disease threatens as Kashmir flood waters turn fetid  Full Article 

Hashmi's New Film

Hashmi's New Film

For Oscar-winning Tanovic, Emraan Hashmi’s “serial kisser” tag didn’t matter.  Full Article 

Afghan Attack

Afghan Attack

Bomb attack kills 4 foreign troops in Afghan capital - coalition.  Full Article 

Fresh Demand

Fresh Demand

As mining curbs bite, India offers market to glut-hit iron ore.  Full Article 

Drug Approval

Drug Approval

Epirus, Ranbaxy win India approval for arthritis drug copy.  Full Article 

Anelka in ISL

Anelka in ISL

Anelka joins Mumbai in Indian Super League  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage